Who invested in MicuRx Pharmaceuticals?
MicuRx Pharmaceuticals's investors include Morningside Group, Devon Park BioVentures, BVCF and GP Healthcare Capital.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$90Mraised across 3 rounds since 2007, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From MicuRx Pharmaceuticals's own website: 6 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MicuRx Pharmaceuticals's investors include Morningside Group, Devon Park BioVentures, BVCF and GP Healthcare Capital.
MicuRx Pharmaceuticals has raised $90M across 3 rounds since 2007.
MicuRx Pharmaceuticals's most recent round was a Series C of $55M in Sept 2016.
Its most recent round, $55M in Sept 2016, is also its largest on record.
MicuRx Pharmaceuticals's first round on record, in Jun 2007, was backed by Morningside Group.
MicuRx Pharmaceuticals's latest named round is a Series C, in Sept 2016.
MicuRx Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.